List of SciY ArxSpan ELN Customers
Billerica, 01821, MA,
United States
Since 2010, our global team of researchers has been studying SciY ArxSpan ELN customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased SciY ArxSpan ELN for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using SciY ArxSpan ELN for Laboratory Management include: Sunovion Pharmaceuticals, a United States based Life Sciences organisation with 2500 employees and revenues of $320.0 million, CatSci, a United Kingdom based Manufacturing organisation with 100 employees and revenues of $10.0 million, Constellation Pharmaceuticals, a United States based Life Sciences organisation with 70 employees and revenues of $9.0 million and many others.
Contact us if you need a completed and verified list of companies using SciY ArxSpan ELN, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The SciY ArxSpan ELN customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
CatSci | Manufacturing | 100 | $10M | United Kingdom | SciY | SciY ArxSpan ELN | Laboratory Management | 2020 | n/a |
In 2020, CatSci implemented SciY ArxSpan ELN in its analytical laboratories as a Laboratory Management solution, establishing a formal digital record for R&D experiments and QC handoffs. SciY ArxSpan ELN was used to instrument analytical data flows and to align laboratory practice with service delivery requirements for CatSci’s contract research and analytical services.
The deployment included the Integrated Analytical Instruments module to automate capture and processing of NMR and mass spectrometry data, embedding instrument-to-record ingestion and automated spectral file association with experiment records. Configuration emphasized functional workflows common to Laboratory Management, including electronic experiment notebooks, instrument data capture, and linkage of R&D entries to QC workflows to preserve provenance and streamline sample-result relationships.
Operational coverage focused on CatSci’s analytical labs within its service operations, centralizing laboratory data and standardizing data capture across teams. The implementation reduced manual data handling, reclaimed scientist time for interpretation, and improved laboratory data centralization across CatSci’s service operations, while governance centered on consistent electronic record creation and automated instrument data reconciliation.
|
 |
Constellation Pharmaceuticals | Life Sciences | 70 | $9M | United States | SciY | SciY ArxSpan ELN | Laboratory Management | 2019 | n/a |
In 2019, Constellation Pharmaceuticals implemented SciY ArxSpan ELN to provide global web-based access for its Cambridge-based R&D teams and international CROs. SciY ArxSpan ELN, categorized as Laboratory Management, was deployed to support web-native experiment recording and centralized electronic lab notebook functions across the organization.
The implementation preserved regulatory controls including e-signatures and versioning, and was configured to maintain audit trails and controlled document workflows. Functional configuration emphasized Laboratory Management capabilities such as experiment capture, protocol templates, controlled record versioning, and automated signing workflows to accelerate approvals and record finalization.
Operational rollout covered roughly 60 to 70 users, spanning Cambridge R&D staff and collaborating international CROs, delivered via web access to reduce desktop support demands. The web-based delivery centralized software access and reduced ongoing IT intervention for client installations and upgrades.
Post-implementation outcomes explicitly included cutting IT maintenance and upgrade costs, eliminating desktop-support backlogs for about 60 to 70 users, and enabling faster data upload and signing workflows. Governance was tightened around e-signature policies and version control to preserve regulatory compliance across internal research teams and external CRO partners.
|
 |
Sunovion Pharmaceuticals | Life Sciences | 2500 | $320M | United States | SciY | SciY ArxSpan ELN | Laboratory Management | 2019 | n/a |
In 2019, Sunovion Pharmaceuticals deployed SciY ArxSpan ELN as a Laboratory Management application to support R&D across medicinal chemistry, biology, and analytical chemistry. The cloud-hosted SciY ArxSpan ELN centralized experiment records and enabled secure sharing across internal teams and external partners.
The implementation emphasized electronic experiment capture, structured protocol management, searchable experiment indexing, role based access controls, and audit trails to support quality assurance and regulatory recordkeeping. Configuration included standardized templates for chemical and biological workflows to improve data consistency and reduce manual transcription.
Operational scope covered corporate R&D laboratories and collaboration with contract research organizations across Europe and Asia, enabling real-time communication between corporate and CRO labs. The deployment used a cloud-first architecture to lower IT overhead and to provide shared project workspaces and secure data exchange for cross-site studies.
Governance changes centered on centralizing QA access to ELN records and establishing shared documentation controls for cross-site studies, improving oversight of experimental data. Reported outcomes included reduced IT overhead, measurable time-savings in data access, and improved QA visibility and real-time collaboration between Sunovion and CRO partners.
|
Buyer Intent: Companies Evaluating SciY ArxSpan ELN
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||